Palmitoyl Hexapeptide-19 (BoNT-L Peptide)_Dosage, benefits & legal status
Also known as BoNT-L Peptide, BONT-L, BoNT-L-Peptide, palmitoyl hexapeptide 19
A Botox-like cosmetic peptide whose published evidence is 15 volunteers and a supplier's own testing.
What is Palmitoyl Hexapeptide-19 (BoNT-L Peptide)?
Plain language first. The technical label stays, but it never stands alone.Overview
A topical peptide sold on a comparison to Botox, with the supplier's own testing behind it.
A palmitoylated cosmetic hexapeptide marketed under the BoNT-L Peptide trade name for expression-line smoothing, with a claimed SNARE-interference mechanism and no independent controlled trial.
What it's used for
A topical anti-wrinkle peptide used in creams and serums for expression lines around the eyes and forehead.
How does Palmitoyl Hexapeptide-19 (BoNT-L Peptide) work?
What it does in the body, and where.The supplier's claim is that this peptide interferes with the SNARE complex, the machinery a nerve ending uses to release acetylcholine onto a muscle. That is the same claimed mechanism family as Argireline, already on this site, which mimics a stretch of SNAP-25. The palmitic acid tail is there to get a water-loving peptide through the outer layer of skin.
- 01The fatty tail is what gets it inA bare six-residue peptide is too water-loving to cross the stratum corneum. Attaching a 16-carbon palmitic acid chain trades water solubility for the ability to pass a lipid barrier. It is the same modification used on Matrixyl and on Palmitoyl Tetrapeptide-10.
- 02The claim is interference with SNAP-25A peer-reviewed review of cosmetic peptides describes this ingredient as able to inactivate SNAP-25 by inhibiting formation of the SNARE protein complex. SNAP-25 is one of the proteins botulinum toxin cleaves, which is where the name BoNT-L comes from.
- 03Botulinum toxin does something differentBotulinum toxin is an enzyme injected into a muscle, where it cuts SNAP-25 and paralyzes the nerve ending for months. A topical peptide applied to the skin surface is not reaching a neuromuscular junction in any comparable way. Sharing a target protein in a diagram is not the same as sharing an effect.
- 04What has actually been measuredThe figures that circulate come from the supplier. A cream at 5 percent of the solution, tested for 28 days on 15 volunteers, reporting an average 38 percent reduction in the macro-relief of skin. A 10 percent cream applied twice daily for 28 days, reporting up to 63 percent less wrinkle depth around the eye. No independent controlled trial of this peptide alone was found.

What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Skin conditioning, the function the cosmetic ingredient inventory assigns itnone
- Softening expression lines, which is what the supplier markets it fornone
- Blocking acetylcholine release by interfering with SNARE complex formation, the supplier's stated mechanismnone
The published record
0
Papers about Palmitoyl Hexapeptide-19 (BoNT-L Peptide) · this compound only
Searched: Palmitoyl Hexapeptide-19, BoNT-L Peptide.
Left out: BoNT (the standard abbreviation for botulinum neurotoxin, a different thing entirely); botulinum (the toxin itself, written out); Hexapeptide-19 (the version without the fatty tail, and part of this peptide's own name); Acetyl Hexapeptide-8 (a different cosmetic peptide, already covered on its own page); Argireline (that peptide's trade name); Acetyl Hexapeptide-3 (that peptide's older name); Palmitoyl Hexapeptide-12 (a different cosmetic peptide, already covered on its own page); Palmitoyl Hexapeptide-52 (a different hexapeptide that is easy to confuse with this one); SNAP-25 (the protein in the claimed mechanism, with a very large literature of its own); SNARE (the protein complex in the claimed mechanism, with an even larger one); acetylcholine (a neurotransmitter, with one of the largest literatures in biology); Inyline (a different cosmetic peptide sold on a similar claim); Munapsys (another cosmetic peptide sold on a similar claim); DDMNKK (a sequence that circulates on ingredient directories but is not published by the developer); retail brand names (finished skincare products, which return marketing rather than research).
Europe PMC was searched on November 20, 2026 for these terms and returned nothing.
Counted from Europe PMC indexing, not read by a person.

At a glance
Four things to know about Palmitoyl Hexapeptide-19 (BoNT-L Peptide)
Evidence
Cosmetic
Category
Skin and cosmetic
Common vial
Varies
Half-life
Not measured, and not the right question
How much, and do you cycle it?
The range, and whether you take breaks.Set by the finished product, daily, as directed by the product. Not cycled Community practice
Used daily as part of a routine. Nothing about it suggests tolerance or a need for a break, and nothing has been studied that would show either way.
Not measured, and not the right questionNo figure
No half-life has been published. It is applied to the skin in a finished cosmetic rather than dosed into the bloodstream, so a circulating half-life would not describe anything useful. The relevant question for a lipidated topical peptide is how much penetrates and how long it persists in the tissue, and that has not been published for this one.
You can compare this against the whole library to see where it sits.
How is it given?
Dosing context and source notes.Supplied as a ready-made solution, so there is nothing to mix.
No use level for the peptide itself has been published. What is published is the use level of the preparation, which is a different number: the supplier's material is a solution whose declared composition is water and this peptide, and a peer-reviewed review of cosmetic peptides reports testing at 5 percent of that solution in a cream, and separately at 10 percent in a cream applied twice daily. Those are supplier use levels for a diluted preparation, not concentrations of the peptide, and the peptide's share of the solution is not disclosed in any document read here. A powder form of the same trade ingredient also exists, for which no use level was found.
How do you store it?
Before mixing, and after.Room temperature, out of light. Cap it tight after each use.
Palmitoyl Hexapeptide-19 (BoNT-L Peptide) ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.
What are the side effects and cautions?
Known cautions and warnings for this compound.Who should avoid it
- A known allergy to this ingredient or to others in the same product
- Broken, cracked, or actively irritated skin
- Anyone expecting the effect of a botulinum toxin injection, which this does not deliver
Stop and get help
- A rash that spreads beyond where you applied it
- Swelling of the face, lips, or eyelids, or any trouble breathing
- Burning that does not settle after rinsing it off
Common effects
- No adverse effects are reported for the isolated peptide, and no published testing has looked for them.
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is Palmitoyl Hexapeptide-19 (BoNT-L Peptide) approved?
And where the numbers on this page come from.Not as a medicine. Palmitoyl Hexapeptide-19 (BoNT-L Peptide) is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.
- Approval statusCosmeticSold without a prescription as an ingredient in cosmetics, such as skincare and hair products. The FDA does not approve cosmetics before they are sold, and being easy to buy says nothing about whether it works.
- RouteOn the skin (topical)
- Checked19 November 2026
- DoseNo dose has been established in people.
- Vial sizeFrom what vendors typically list; not a recommendation.
- SourcesCosmetics 8(3):66, Neurocosmetics in Skincare, The Fascinating World of Skin-Brain Connection, a review of ingredients, commercial products for skin aging, and cosmetic regulationWO2016097966A1, Tripeptides, compositions thereof and their cosmetic usesWO2017163174A1, Cosmetic use of an ingredient derived from Marrubium vulgareLa Cosmetotheque, Muscular beauty part 4, the Botox like or Cosmetic Botox
What has happened recently
We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.
You can compare this against the whole library, or read how to check a seller.
What else is like Palmitoyl Hexapeptide-19 (BoNT-L Peptide)?
Others in Skin and cosmetic, side by side.If you're weighing Palmitoyl Hexapeptide-19 (BoNT-L Peptide), it's worth reading Palmitoyl Tetrapeptide-10, Palmitoyl Tripeptide-8, and Progeline (Trifluoroacetyl Tripeptide-2) in the same class.
A Botox-like cosmetic peptide whose published evidence is 15 volunteers and a supplier's own testing.
- Dose
- Set by the finished product
- How often
- Daily, as directed by the product
A fatty-tailed cosmetic tetrapeptide with a labeling problem worth understanding.
- Dose
- Set by the finished product
- How often
- Daily, as directed by the product
A skin-calming ingredient built from three residues of a natural anti-inflammatory hormone, backed mainly by supplier tests.
- Dose
- Serum or cream, per product
- How often
- Daily
A topical peptide aimed at sagging rather than lines, borrowed from progeria research.
- Dose
- Serum, per product
- How often
- Daily
Guides for this compound
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
- How to Vet a Peptide Vendor
Independent COAs, HPLC purity, and the red flags that mean walk away.
Sources
- Cosmetics 8(3):66, Neurocosmetics in Skincare, The Fascinating World of Skin-Brain Connection, a review of ingredients, commercial products for skin aging, and cosmetic regulation(2021)A peer-reviewed review of cosmetic peptides, used here as the strongest non-supplier source for both the identity and the testing figures. It lists BONT-L Peptide Solution with the INCI name palmitoyl hexapeptide-19, attributes it to Infinitec, gives its declared composition as water and palmitoyl hexapeptide-19, and describes the claimed mechanism as inactivating SNAP-25 by inhibiting formation of the SNARE protein complex. It reports that a cream containing 5 percent BONT-L Peptide was tested for 28 days on 15 volunteers with an average 38 percent reduction of the macro-relief of human skin, and separately that a 10 percent cream applied twice a day for 28 days produced a reduction in wrinkle depth around the eye of up to 63 percent. A powder form of the same ingredient is listed alongside the solution.
- WO2016097966A1, Tripeptides, compositions thereof and their cosmetic uses(2016)A cosmetic patent that states the inventory definition verbatim, read for the composition. It gives BONT-L-Peptide with the INCI name Palmitoyl Hexapeptide-19, defined as the reaction product of palmitic acid and Hexapeptide-19, a synthetic peptide constituted of asparagine, aspartic acid, lysine and methionine. The same definition appears in at least two further patents in unrelated families, which is why it is treated here as the settled description rather than a single document's wording.
- WO2017163174A1, Cosmetic use of an ingredient derived from Marrubium vulgare(2017)A second, independent patent carrying the identical definition, cited to show the composition is not one document's phrasing. It lists BONT-L-Peptide with the INCI name Palmitoyl Hexapeptide-19 as the reaction product of palmitic acid and Hexapeptide-19, a synthetic peptide constituted of asparagine, aspartic acid, lysine and methionine, in a list of peptides suitable for use in the invention.
- La Cosmetotheque, Muscular beauty part 4, the Botox like or Cosmetic Botox(2021)An industry history of cosmetic botulinum-toxin alternatives, read at source and used to place this ingredient and to confirm the developer. It records that a peptide developed by the Spanish company Infinitec Activos, called BoNT-L with the INCI name Palmitoyl Hexapeptide-19, emerged among newer specialties after Argireline, and sets out how the whole Botox-like category came about.
